Breast Cancer Risk-Reducing Medications.
Publication
, Journal Article
Graham, D; DiNome, ML; Ganz, PA
Published in: JAMA
July 21, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 21, 2020
Volume
324
Issue
3
Start / End Page
310
Location
United States
Related Subject Headings
- Tamoxifen
- Selective Estrogen Receptor Modulators
- Risk Factors
- Raloxifene Hydrochloride
- Humans
- General & Internal Medicine
- Female
- Breast Neoplasms
- Aromatase Inhibitors
- Anticarcinogenic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Graham, D., DiNome, M. L., & Ganz, P. A. (2020). Breast Cancer Risk-Reducing Medications. JAMA, 324(3), 310. https://doi.org/10.1001/jama.2020.11784
Graham, Danielle, Maggie L. DiNome, and Patricia A. Ganz. “Breast Cancer Risk-Reducing Medications.” JAMA 324, no. 3 (July 21, 2020): 310. https://doi.org/10.1001/jama.2020.11784.
Graham D, DiNome ML, Ganz PA. Breast Cancer Risk-Reducing Medications. JAMA. 2020 Jul 21;324(3):310.
Graham, Danielle, et al. “Breast Cancer Risk-Reducing Medications.” JAMA, vol. 324, no. 3, July 2020, p. 310. Pubmed, doi:10.1001/jama.2020.11784.
Graham D, DiNome ML, Ganz PA. Breast Cancer Risk-Reducing Medications. JAMA. 2020 Jul 21;324(3):310.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 21, 2020
Volume
324
Issue
3
Start / End Page
310
Location
United States
Related Subject Headings
- Tamoxifen
- Selective Estrogen Receptor Modulators
- Risk Factors
- Raloxifene Hydrochloride
- Humans
- General & Internal Medicine
- Female
- Breast Neoplasms
- Aromatase Inhibitors
- Anticarcinogenic Agents